Tscan therapeutics presents promising updated phase 1 clinical results on tsc-100 and tsc-101 at the 2024 tandem meetings of astct and cibmtr

All eight (100%) treatment-arm patients are relapse-free and have achieved and maintained complete donor chimerism following treatment with tsc-100 or tsc-101

TCRX Ratings Summary

TCRX Quant Ranking